Animal models of type 2 diabetes: Clinical presentation and pathophysiological relevance to the human condition

ILAR Journal

Volumn 47, Issue 3, 2006, Pages 186-198

  Cefalu, William T ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Animal models; Felines; Glucose; Insulin; Primates; Rodents; Swine

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; GLUCOSE; INSULIN; STREPTOZOCIN;

ALLOXAN DIABETES MELLITUS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAT; CLINICAL FEATURE; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MODEL; GENETIC ENGINEERING; GERBIL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MORBIDITY; MORTALITY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIMATE; RAT; SPECIES DIFFERENCE; STREPTOZOCIN DIABETES; SWINE;

ANIMALIA;

EID: 33745595310     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.47.3.186     Document Type: Article

References (124)

1. Adler JH, Lazarovici G, Marton M, Ben-Sasson R, Ziv E, Bar-On H, Rosenmann E. 1988 Patterns of hyperglycemia hyperinsulinemia and pancreatic insufficiency in sand rats (Psammomys obesus). In: Lessons from Animal Diabetes. London: J. Libbey. p 384-388.
2. Adler JH, Roderig C, Gutman A. 1976. Breeding sand rats (Psammomys obesus) with a diabetic predisposition for laboratory investigations. Refuah Vet 22:1-8.
3. Adult Treatment Panel III [Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults]. 2001. JAMA 285:2486-2497.
4. Anderson MS, Bluestone JA. 2005. The NOD mouse: A model of immune dysregulation. Annu Rev Immunol 23:447-485.
5. Appleton DJ, Rand JS, Sunvold GD. 2001. Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain. J Feline Med Surg 3:211-228.
6. Askari B, Carroll MA, Capparelli M, Kramer F, Gerrity RG, Bornfeldt KE. 2002. Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells. J Biol Chem 277:36338-36344.
7. Baetens D, Stefan Y, Ravazzola M, Malaisse-Lagae F, Coleman DL, Orci L. 1978. Alteration of islet cell populations in spontaneously diabetic mice. Diabetes 27:1-7.
8. Banks WA, Altmann J, Sapolsky RM, Phillips-Conroy JE, Morley, JE. 2003. Serum leptin levels as a marker for a syndrome X-like condition in wild baboons. J Clin Endo Metab 88:1234-1240.
9. Barker JM. 2006. Type 1 diabetes associated autoimmunity: Natural history, genetic associations and screening. J Clin Endocrinol Metab 91: 1210-1217.
10. Bates SH, Kulkarni RN, Seifert M, Myers MG Jr. 2005. Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis. Cell Metab 1:169-178.
11. Bellinger DA, Merricks EP, Nichols TC. 2006. Swine models of type 2 diabetes mellitus: Insulin resistance, glucose tolerance, and cardiovascular complications. ILAR J 47:243-258.
12. Betsholtz C, Svensson V, Rorsman F, Engstrom U, Westermark GT, Wilander E, Johnson K, Westermark P. 1989. Islet amyloid polypeptide (IAPP):cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res 183:484-493.
13. Black BL, Croom J, Eisen EJ, Petro AE, Edwards CL, Surwit RS. 1998. Differential effects of fat and sucrose on body composition in A/J and C57BL/6 mice. Metabolism 47:1354-1359.
14. Bodkin NL. 2000. The rhesus monkey (Macaca mulatta): A unique and valuable model for the study of spontaneous diabetes mellitus and associated conditions. In: Sima AF, Shafrir E, eds. Animal Models in Diabetes: A Primer. Singapore: Taylor & Francis, Inc. p 309-325.
15. Bodkin NL, Alexander TM, Ortmeyer HK, Johnson E, Hansen BC. 2003. Mortality and morbidity in laboratory-maintained rhesus monkeys and effects of long-term dietary restriction. J Gerontol 58A:212-219.
16. Brodala N, Merricks EP, Bellinger DA, Damrongsri D, Offenbacher S, Beck J, Madianos P, Sotres D, Chang YL, Koch G, Nichols TC. 2005. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 25:1456-1451.
17. Buchanan TA. 2003. Pancreatic beta-cell loss and preservation in type 2 diabetes. Clin Ther 25(Suppl B):B32-B46.
18. Butler AE. Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC. 2004. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat): A new model for type 2 diabetes. Diabetes 53:1509-1516.
19. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. 2003. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110.
20. Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA. 1990. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39:752-756.
21. Cai G, Cole SA, Tejero E, Proffitt JM, Freeland-Graves JH, Blangero J, Comuzzie AG. 2004. Pleiotropic effects of genes for insulin resistance on adiposity in baboons. Obesity Res 12:1766-1772.
22. CDC [Centers for Disease Control and Prevention]. 2003. Diabetes prevalence among American Indians and Alaska Natives and the overall population - United States, 1994-2. MMWR 52:702-704.
23. Cefalu WT. 2000. Insulin resistance. In: Leahy J, Clark N, Cefalu WT, eds. The Medical Management of Diabetes Mellitus. New York: Marcel Dekker, Inc. p 57-75.
24. Cefalu WT, Wang ZQ, Bell Farron AD, Collins J, Morgan T, Wagner JD. 2004. Caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): Metabolic, physiologic, and atherosclerotic measures from a 4-year intervention trial. J Geronol 59A:1007-1014.
25. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. 1996. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495.
26. Chung WK, Power-Kehoe L, Chua M, Lee R, Leibel RL. 1996. Genomic structure of the human OB receptor and identification of two novel intronic microsatellites. Genome Res 6:1192-1199.
27. Clarkson TB. 1998. Nonhuman primate models of atherosclerosis. Lab Anim Sci 48:569-572.
28. Clarkson TB, Koritnik DR, Weingand KW, Miller LC. 1985. Nonhuman primate models of atherosclerosis: Potential for the study of diabetes mellitus and hyperinsulinemia. Metabolism 34(Suppl 1):51-59.
29. Cromeens DM, Stephens LC. 1985. Insular amyloidosis and diabetes mellitus in a crab-eating macaque (Macaca fascicularis). Lab Anim Sci 35:642-645.
30. DCCT Research Group [Diabetes Control and Complications Trial Research Group]. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986.
31. de Koning EJP, Bodkin NL, Hansen BC, Clarks A. 1993. Diabetes mellitus in Macaca mulatta monkeys is characterized by islet amyloidosis and reduction in beta-cell population. Diabetologia 36:378-384.
32. DeFronzo RA. 1992. Insulin resistance, hyperinsulinemia, and coronary artery disease: A complex metabolic web. J Cardiovasc Pharmacol 20(Suppl 11):S1-S16.
33. Donath MY, Gross DJ, Cerasi E, Kaiser N. 1999. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738-744.
34. Evans RM, Barish GD, Wang YU. 2004. PPARs and the complex journey to obesity. Nat Med 10:355-361.
35. Feldhahn JR, Rand JS, Martin G. 1999. Insulin sensitivity in normal and diabetic cats. J Feline Med Surg 1:107-115.
36. Fettman MJ, Stanton CA, Banks LL, Johnson DE, Hamar DW, Hegstad RL, Johnston S. 1998. Effects of weight gain and loss on metabolic rate, glucose tolerance, and serum lipids in domestic cats. Res Vet Sci 64:11-16.
37. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE. 2001. Beta-cell mass dynamics in Zucker diabetic fatty rats: Rosiglitazone prevents the rise in net cell death. Diabetes 50: 1021-1029.
38. Ford ES, Giles WH, Dietz WH. 2002. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359.
39. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. 2001. Diabetes-induced accelerated atherosclerosis in swing. Diabetes 50:1654-1665.
40. Gresl TA, Coleman RJ, Roecker EB, Havighurst TC, Huang Z, Allison DB, Burgman RN, Kemnitz JW. 2001. Dietary restriction and glucose regulation in aging rhesus monkeys: A follow-up report at 8.5 yr. Am J Physiol Endocrinol Metab 281:E757-E765.
41. Haffner SM. 1996. The insulin resistance syndrome revisited. Diabetes Care 19:275-277.
42. Hainsworth DP, Katz ML, Sanders DA, Sanders DN, Wright EJ, Sturek M. 2002. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus. Comp Med 52:523-529.
43. Hamilton CL, Ciaccia P. 1978. The course of development of glucose intolerance in the monkey (Macaca mulatta). J Med Primatol 7:165-173.
44. Hansen BC, Bodkin NL. 1986. Heterogeneity of insulin responses: Phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 29:713-719.
45. Harmon JS, Gleason CE, Tanaka Y, Poitout V, Robertson RP. 2001. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes 50:2481-2486.
46. Henson MS, O'Brien TD. 2006. Feline models of type 2 diabetes. ILAR J 47:234-242.
47. Hogan P, Dall T, Nikolov P; American Diabetes Association. 2003. Economic costs of diabetes in the US in 2002. Diabetes Care 26:917-932.
48. Hoppener JWM, Ahren B, Lips CJM. 2000. Islet amyloid and type 2 diabetes mellitus. N Engl J Med 343:411-419.
49. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y. 2001. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126-1133.
50. Howard CF. 1986. Changes in islet cell composition during development of diabetes in Macaca nigra. Diabetes 35:165-171.
51. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. 2002. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25:1129-1134.
52. Hubbard GB, Steele KE, Davis Kj, Leland MM. 2002. Spontaneous pancreatic islet amyloidosis in 40 baboons. J Med Primatol 31:84-90.
53. Hunter SJ, Garvey WT. 1998. Insulin action and insulin resistance: Diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am J Med 105:331-345.
54. Ikegami H, Fujisawa T, Ogihara T. 2004. Mouse models of type 1 and type 2 diabetes derived from the same closed colony: Genetic susceptibility shared between two types of diabetes. ILAR J 45:268-277.
55. Isomaa B. Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689.
56. Johansen T, Hansen HS, Richelsen B, Malmlof R. 2001. The obese Göttingen minipig as a model of the metabolic syndrome: Dietary effects on obesity, insulin sensitivity, and growth hormone profile. Comp Med 51:150-155.
57. Johnson KH, Hayden DW, O'Brien TD, Westermark P. 1986. Spontaneous diabetes mellitus-islet amyloid complex in adult cats. Am J Pathol 125:416-419.
58. Johnson KB, O'Brien TD, Betsholtz C, Westermark P. 1989. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. N Engl J Med 321: 513-518.
59. Kahn SE. 2000. The importance of the beta-cell in the pathogenesis of type 2 diabetes. Am J Med 108(Suppl 6a):2S-8S.
60. Kahn SE, Andrikopoulos S, Verchere CB. 1999. Islet amyloid: A long-recognized but underappreciated feature of type 2 diabetes. Diabetes 48:241-253.
61. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP. 1993. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: Evidence for a hyperbolic function. Diabetes 42:1663-1672.
62. Kalderon B, Gutman A, Levy E, Shafrir E, Adler JH. 1986. Characterization of stages in the development of obesity-diabetes syndrome in the sand rat (Psammomys obesus). Diabetes 35:717-724.
63. Kawasaki F. Matsuda M, Kanda Y, Inoue H, Kaku K. 2005. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/ db mice. Am J Physiol Endocrinol Metab 288:E510-E518.
64. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N. 2001. G]ycated hemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). Br Med J 322:15-18.
65. Kulkarni RN, Almind K, Goren HJ, Winnay JN, Ueki K, Okada T, Kahn CR. 2003. Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. Diabetes 52:1528-1534.
66. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. 2002. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716.
67. Larsen MO, Rolin B, Wilken M, Carr RD, Svendsen O, Bollen P. 2001. Parameters of glucose and lipid metabolism in the male Göttingen minipig: Influence of age, body weight, and breeding family. Comp Med 51: 436-442.
68. Larsen MO, Rolin B. 2004. Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J 45: 303-313.
69. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. 1994. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A 91:10878-10882.
70. Leiter EH, Reifsnyder PC. 2004. Differential levels of diabetogenic Stress in two new mouse models of obesity and type 2 diabetes. Diabetes 53(Suppl 1):S4-S11.
71. Liese AD, Mayer-Davis EJ, Haffner SM. 1998. Development of the multiple metabolic syndrome: An epidemiologic perspective. Epidemiol Rev 20:157-172.
72. Loskutoff DJ, Fujisawa K, Samad F. 2000. The fat mouse: A powerful genetic model to study hemostatic gene expression in obesity/NIDDM. Ann N Y Acad Sci 902:272-281.
73. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY. 2002. Glucose-induced beta cell production of IL-1-beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860.
74. Mathis D, Venece L, Benoist C. 2001. Beta-cell death during progression to diabetes. Nature 414:792-798.
75. Matveyenko AV, Butler PC. 2006. IAPP transgenie rodents as models for type 2 diabetes. ILAR J 47:225-233.
76. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. 2004. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 53:495-499.
77. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks. 2003. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79.
78. Movassat J, Saulnier C, Serradas P, Portha B. 1997. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat. Diabetologia 40:916-925.
79. Natarajan R, Gerrity RG, Gu JL, Lanting L, Thomas L, Nadler JL. 2002. Role of 12-lipoxygenase and oxidant stress in hyperglycemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia 45:125-133.
80. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Laehin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. 2005. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653.
81. Neubauer N, Kulkarni RN. 2006. Molecular approaches to study control of glucose homeostasis. ILAR J 47:199-211.
82. Nichols TC, Bellinger DA, Davis RE, Koch GG, Reddick RL, Read MS, Rapacz J, Hasler-Rapacz J, Brinkhous KM, Griggs TR. 1992. Porcine von Willebrand disease and atherosclerosis: Influence of polymorphism in apolipoprotein B100 genotype. Am J Pathol 140:403-415.
83. O'Brien TD, Butler PC, Westermark P, Johnson KH. 1993. Islet amyloid polypeptide: A review of its biology and potential roles in the pathogenesis of diabetes mellitus. Vet Pathol 30:317-332.
84. O'Brien TD, Hayden DW, Johnson KH, Fletcher TF. 1986. Immunohistochemical morphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal cats. J Comp Pathol 96: 357-369.
85. O'Brien TD, Hayden DW, Johnson KH, Stevens JB. 1985. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: Relationships to insular amyloidosis. Vet Pathol 22:250-261.
86. O'Brien TD, Wagner JD, Litwak RN, Carlson CS, Cefalu WT, Jordan K, Johnson KH, Butler PC. 1996. Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (Macaca fascicularis): An animal model of human non-insulin dependent diabetes mellitus. Vet Pathol 33:479-485.
87. Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MA. 2005. Oxidative-nitrosative stress and poly (ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: The relation is revisited. Diabetes 54:3435-3441.
88. Obrosova IG, Fathallah L, Liu E, Nourooz-Zadeh J. 2003. Early oxidative stress in the diabetic kidney: Effect of DL-alpha-lipoic acid. Free Radic Biol Med 34:186-195.
89. Ohagi S, Nishi M, Bell GI, Ensinck JW, Steiner DF. 1991. Sequences of islet amyloid polypeptide precursors of an Old World monkey, the pig-tailed macaque (Macaca nemestrina) and the dog (Canis familiaris). Diabetologia 34:555-558.
90. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. 1995. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diab Res Clin Pract 28:103-117.
91. Panciera DL, Thomas CB, Eicker SW, Atkins CE. 1990. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). J Am Vet Med Assoc 197:1504-1508.
92. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ, Hess JF. 1996. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13:18-19.
93. Phillips RW, Panepinto LM. 1986. Swine as a model for human diabetes. In: Tumbleson MD, ed. Swine in Biomedical Research. Vol 1. New York: Plenum Press. 1:549-560.
94. Phillips RW, Panepinto LM, Spangler R, Westmoreland N. 1982. Yucatan miniature swine as a model for the study of human diabetes mellitus. Diabetes 31:30-36.
95. Picarel-Blanchot F, Berthelier C, Bailbe D, Portha B. 1996. Impaired insulin secretion and excessive hepatic glucose production are both early events in the diabetic GK rat. Am J Physiol 271:E755-E762.
96. Portha B, Giroix MH, Serradas P, Gangnerau MN, Movassat J, Rajas F, Bailbe D, Plachot C, Mithieux G, Marie JC. 2001. Beta-cell function and viability in the spontaneously diabetic GK rat: Information from the GK/ Par colony. Diabetes 50(Suppl 1):S89-S93.
97. Prahl A, Glickman L, Guptill L, Glickman N, Tetrick M. 2003. Time trends and risk factors for diabetes mellitus in cats. J Vet Intern Med 17:434.
98. Prescott MF, Hasler-Rapacz J, von Linden-Reed J, Rapacz J. 1995. Familial hypercholesterolemia associated with coronary atherosclerosis in swine bearing different alleles for apolipoprotein B. Ann N Y Acad Sci 748:283-292.
99. Prescott ME, McBride CH, Hasler-Rapacz J, Von Linden J, Rapacz J. 1991. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 139:139-147.
100. Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R. 2004. Canine and feline diabetes mellitus: Nature or nurture? J Nutr 134:2072S-2080S.
101. Reaven GM. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607.
102. Reddi AS, Camerini-Davalos RA. 1988. Hereditary diabetes in the KK mouse: An overview. Adv Exp Med Biol 246:7-15.
103. Reichard P, Nilsson B-Y, Rosenqvist U. 1993. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309.
104. Shafrir E, Ziv E. 1998. Cellular mechanism of nutritionally induced insulin resistance: The desert rodent Psammomys obesus and other animals in which insulin resistance leads to detrimental outcome. J Basic Clin Physiol Pharmacol 9:347-385.
105. Shafrir E, Ziv E, Kalman R. 2006. Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). ILAR J 47:212-224.
106. Shafrir E, Ziv E, Mosthaf L. 1999. Nutritionally induced insulin resistance and receptor defect leading to beta-cell failure in animal models. Ann N Y Acad Sci 892:223-246.
107. Shirai K. 2004. Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Curr Med Res Opin 20:295-304.
108. Stokes WS. 1986. Spontaneous diabetes mellitus in a baboon (Papio cynocephalus anubis). Lab Anim Sci 36:529-533.
109. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. 2000. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. Br Med J 321:405-412.
110. Tigno XT, Gerzanich G, Hansen BC. 2004. Age-related changes in metabolic parameters on nonhuman primates. J Gerontol 59A:1081-1088.
111. Tomita T, Doull V, Pollock HG, Krizsan D. 1992. Pancreatic islets of obese hyperglycemic mice (ob/ob). Pancreas 7:367-375.
112. Ueda H, Ikegami H, Kawaguchi Y, Fujisawa T, Nojima K, Babaya N, Yamada K, Shibata M, Yamato E, Ogihara T. 2000. Age-dependent changes in phenotypes and candidate gene analysis in a polygenic animal model of type II diabetes mellitus: NSY mouse. Diabetologia 43:932-938.
113. UKPDS Group [UK Prospective Diabetes Study Group]. 1998. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853.
114. Wagner JD, Carlson CS, O'Brien TD, Anthony MS, Bullock BC, Cefalu WT. 1996. Diabetes mellitus and islet amyloidosis in cynomolgus monkey. Lab Anim Sci 46:36-41.
115. Wagner JD, Cline JM, Shadoan MK, Bullock BC, Rankin SE, Cefalu WT. 2001. Naturally occurring and experimental diabetes in cynomolgus monkeys: A comparison of carbohydrate and lipid metabolism and islet pathology. Tox Path 29:142-148.
116. Wagner JD, Kavanaugh K, Ward GM, Auerbach BJ, Harwood HJ Jr, Kaplan JR. 2006. Old World primate models of type 2 diabetes mellitus. ILAR J 47:259-271.
117. Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, Burstow D, Brown L. 2003. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ 12:44-50.
118. Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C. 1990. Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A 87:5036-5040.
119. Weyer C, Bogardus C, Mott DM, Pratley RE. 1999. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794.
120. Weyer C. Tataranni PA, Bogardus C, Pratley RE. 2001. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24:89-94.
121. WHO [World Health Organization]. WHO Technical Report. 2000. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Geneva: World Health Organization 2000. WHO Technical Report Series 894.
122. Yasuda M, Takaoka M, Fujiwara T, Mori M. 1988. Occurrence of spontaneous diabetes mellitus in a cynomolgus monkey (Macaca fascicularis) and impaired glucose tolerance in its descendants. J Med Primatol 17:319-332.
123. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432.
124. Zimmet P, Alberti KG, Shaw J. 2001. Global and societal implications of the diabetes epidemic. Nature 414:782-787.